p-Valerylphenol

For research use only. Not for therapeutic Use.

  • CAT Number: I014657
  • CAS Number: 2589-71-1
  • Molecular Formula: C11H14O2
  • Molecular Weight: 178.23
  • Purity: ≥95%
Inquiry Now

p-Hydroxyvalerophenone(Cat No.:I014657), also referred to as 4-n-pentanoylphenol, serves as an organic intermediate and pharmaceutical intermediate. It finds application in the synthesis of acyl phenoxy acetic acid compounds. The compound can be prepared via a one-step process by reacting phenol with n-pentanol chloride. This synthetic pathway allows for the efficient production of p-Hydroxyvalerophenone, enabling its use in the development of various pharmaceuticals and other chemical compounds.


Catalog Number I014657
CAS Number 2589-71-1
Synonyms

p-Valerylphenol; NSC 49186; NSC-49186; NSC49186;1-PentaNA, 1-(4-hydroxyphenyl)-

Molecular Formula C11H14O2
Purity ≥95%
Solubility Soluble in DMSO
Storage Room Temperature
IUPAC Name 1-(4-hydroxyphenyl)pentan-1-one
InChI InChI=1S/C11H14O2/c1-2-3-4-11(13)9-5-7-10(12)8-6-9/h5-8,12H,2-4H2,1H3
InChIKey ZKCJJGOOPOIZTE-UHFFFAOYSA-N
SMILES CCCCC(=O)C1=CC=C(C=C1)O
Reference

</br> 1: Bernardes CP, Menaldo DL, Mamede CC, Zoccal KF, Cintra AC, Faccioli LH, Stanziola L, de Oliveira F, Sampaio SV. Evaluation of the local inflammatory events induced by BpirMP, a metalloproteinase from Bothrops pirajai venom. Mol Immunol. 2015 Dec;68(2 Pt B):456-64. doi: 10.1016/j.molimm.2015.09.023. Epub 2015 Oct 21. PubMed PMID: 26468034.</br>2: Dhull DK, Bhateja D, Dhull RK, Padi SS. Differential role of cyclooxygenase isozymes on neuronal density in hippocampus CA1 region of intracerebroventricular streptozotocin treated rat brain. J Chem Neuroanat. 2012 Jan;43(1):48-51. doi: 10.1016/j.jchemneu.2011.10.001. Epub 2011 Oct 6. PubMed PMID: 22001294.</br>3: Dhull DK, Jindal A, Dhull RK, Aggarwal S, Bhateja D, Padi SS. Neuroprotective effect of cyclooxygenase inhibitors in ICV-STZ induced sporadic Alzheimer’s disease in rats. J Mol Neurosci. 2012 Jan;46(1):223-35. doi: 10.1007/s12031-011-9583-6. Epub 2011 Jun 24. PubMed PMID: 21701788.</br>4: Masaki K, Hashimoto M, Imai T. Intestinal first-pass metabolism via carboxylesterase in rat jejunum and ileum. Drug Metab Dispos. 2007 Jul;35(7):1089-95. Epub 2007 Mar 28. PubMed PMID: 17392394.</br>5: Akarsu ES, Ozdayi S, Algan E, Ulupinar F. The neuronal excitability time-dependently changes after lipopolysaccharide administration in mice: possible role of cyclooxygenase-2 induction. Epilepsy Res. 2006 Oct;71(2-3):181-7. Epub 2006 Jul 25. PubMed PMID: 16870400.</br>6: Candelario-Jalil E, González-Falcón A, García-Cabrera M, Alvarez D, Al-Dalain S, Martínez G, León OS, Springer JE. Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia. J Neurochem. 2003 Aug;86(3):545-55. PubMed PMID: 12859668; PubMed Central PMCID: PMC1636020.</br>7: Titos E, Chiang N, Serhan CN, Romano M, Gaya J, Pueyo G, Clària J. Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A(4). Am J Physiol. 1999 Nov;277(5 Pt 1):C870-7. PubMed PMID: 10564079.</br>8: Bhattacharyya DK, Lecomte M, Dunn J, Morgans DJ, Smith WL. Selective inhibition of prostaglandin endoperoxide synthase-1 (cyclooxygenase-1) by valerylsalicylic acid. Arch Biochem Biophys. 1995 Feb 20;317(1):19-24. PubMed PMID: 7872783.</br></br>

Request a Quote